Zevra Therapeutics, Inc. (ZVRA)
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
Teva Releases Q4 2025 Aide Memoire
Edesa Biotech Reports Fiscal Year 2025 Results